Aspirin and Spinal Anesthesia Management
Aspirin (Ecosprin) does NOT need to be discontinued before spinal anesthesia in most patients, as it is considered safe and does not significantly increase the risk of spinal hematoma when used alone. 1, 2
Key Recommendation
The most recent high-quality guidelines from both the American College of Chest Physicians (2022) and the French Working Group on Perioperative Haemostasis (2018) agree that:
- Aspirin monotherapy is NOT a contraindication to spinal anesthesia 1
- If aspirin must be discontinued for high-bleeding-risk spinal procedures, stop it for ≤7 days (not the traditional 7-10 days) 3
- Single-puncture spinal anesthesia is preferable to epidural anesthesia in aspirin-treated patients 1
Clinical Decision Algorithm
Step 1: Assess Aspirin Use Pattern
- Aspirin alone? → Proceed with spinal anesthesia safely 1, 2
- Aspirin + P2Y12 inhibitor (clopidogrel/prasugrel/ticagrelor)? → CONTRAINDICATED - must stop P2Y12 inhibitor 5-7 days before procedure 1
- Aspirin + anticoagulant? → CONTRAINDICATED - follow anticoagulant guidelines 1
Step 2: Evaluate Cardiac Risk
For patients on aspirin for cardiac indications (especially recent stents):
- Recent stent (<1 month)? → Postpone elective surgery if possible 1
- Recent MI or high-risk stent (<6 months)? → Postpone up to 6 months 1
- If surgery cannot be delayed: Continue aspirin, consult cardiology 1
Step 3: Procedure-Specific Considerations
- Standard spinal anesthesia: Safe with aspirin continuation 1, 2
- Epidural catheter placement: Can be performed but single-shot spinal is preferred 1
- High-risk spinal surgery (e.g., complex multilevel): Consider case-by-case discontinuation for ≤7 days 3
Evidence Strength and Nuances
The 2018 French guidelines provide the strongest specific guidance for neuraxial blocks, stating with "strong agreement" that aspirin is not a contraindication to central neuraxial anesthesia if there are no other hemostatic abnormalities 1. This is supported by a comprehensive 2015 review that found no cases of spinal hematoma attributable to aspirin alone, with all reported cases involving additional complicating factors 2.
The 2022 ACCP guidelines acknowledge that spinal procedures are high-bleeding-risk and allow for individualized decisions, but when interruption is chosen, recommend the shorter ≤7-day window rather than the traditional 7-10 days 3.
Critical Pitfalls to Avoid
Do NOT confuse aspirin with P2Y12 inhibitors - P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) ARE contraindicated for spinal anesthesia and must be stopped 5-7 days prior 1
Do NOT combine multiple antiplatelet/anticoagulant agents - The risk of spinal hematoma increases dramatically with combination therapy 1, 2
Do NOT add NSAIDs perioperatively - NSAIDs should not be administered in patients on any antiplatelet therapy 1
Do NOT ignore cardiac risk - Stopping aspirin in high-risk cardiac patients (recent stents, recent MI) may cause life-threatening thrombotic events that outweigh bleeding risks 1
Catheter Management
For epidural catheters in aspirin-treated patients:
- Insertion follows same rules as for spinal anesthesia (safe with aspirin alone) 1
- Catheter removal carries the same risk as insertion - apply identical precautions 1
- Catheter management should not delay resumption of aspirin postoperatively 1
Postoperative Resumption
If aspirin was discontinued:
- Resume ≤24 hours after surgery when hemostasis is adequate 3
- Resume on the same day if bleeding risk allows 1
- Earlier resumption is preferred given thrombotic risks 1
Special Populations
Obstetric patients: Aspirin 75mg for obesity/hypertension does not contraindicate neuraxial blocks if platelet count >75 and coagulation is normal 4
Dual antiplatelet therapy (DAPT): Aspirin should be continued perioperatively; only the P2Y12 inhibitor is stopped 1